113 related articles for article (PubMed ID: 26537573)
1. Short Communication: Analysis of Minor Populations of Human Immunodeficiency Virus by Primer Identification and Insertion-Deletion and Carry Forward Correction Pipelines.
Hughes P; Deng W; Olson SC; Coombs RW; Chung MH; Frenkel LM
AIDS Res Hum Retroviruses; 2016 Mar; 32(3):296-302. PubMed ID: 26537573
[TBL] [Abstract][Full Text] [Related]
2. Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain.
Keys JR; Zhou S; Anderson JA; Eron JJ; Rackoff LA; Jabara C; Swanstrom R
AIDS Res Hum Retroviruses; 2015 Jun; 31(6):658-68. PubMed ID: 25748056
[TBL] [Abstract][Full Text] [Related]
3. Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1 Genomic RNA Populations.
Zhou S; Jones C; Mieczkowski P; Swanstrom R
J Virol; 2015 Aug; 89(16):8540-55. PubMed ID: 26041299
[TBL] [Abstract][Full Text] [Related]
4. Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering.
Novitsky V; Zahralban-Steele M; McLane MF; Moyo S; van Widenfelt E; Gaseitsiwe S; Makhema J; Essex M
J Clin Microbiol; 2015 Aug; 53(8):2581-92. PubMed ID: 26041893
[TBL] [Abstract][Full Text] [Related]
5. Promises and pitfalls of Illumina sequencing for HIV resistance genotyping.
Brumme CJ; Poon AFY
Virus Res; 2017 Jul; 239():97-105. PubMed ID: 27993623
[TBL] [Abstract][Full Text] [Related]
6. Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID.
Jabara CB; Jones CD; Roach J; Anderson JA; Swanstrom R
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20166-71. PubMed ID: 22135472
[TBL] [Abstract][Full Text] [Related]
7. Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA.
Boltz VF; Rausch J; Shao W; Hattori J; Luke B; Maldarelli F; Mellors JW; Kearney MF; Coffin JM
Retrovirology; 2016 Dec; 13(1):87. PubMed ID: 27998286
[TBL] [Abstract][Full Text] [Related]
8. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
[TBL] [Abstract][Full Text] [Related]
9. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
[TBL] [Abstract][Full Text] [Related]
10. Evidence for preferential genotyping of a minority human immunodeficiency virus population due to primer-template mismatching during PCR-based amplification.
Martinez-Picado J; Morales-Lopetegi K; Villena C; Gutiérrez C; Izquierdo N; Marfil S; Clotet B; Ruiz L
J Clin Microbiol; 2005 Jan; 43(1):436-8. PubMed ID: 15635008
[TBL] [Abstract][Full Text] [Related]
11. HIV sequence diversity during the early phase of infection is associated with HIV DNA reductions during antiretroviral therapy.
Wang N; Li Y; Han Y; Xie J; Li T
J Med Virol; 2017 Jun; 89(6):982-988. PubMed ID: 27791274
[TBL] [Abstract][Full Text] [Related]
12. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.
Rose R; Lamers SL; Nolan DJ; Maidji E; Faria NR; Pybus OG; Dollar JJ; Maruniak SA; McAvoy AC; Salemi M; Stoddart CA; Singer EJ; McGrath MS
J Virol; 2016 Oct; 90(20):8984-93. PubMed ID: 27466425
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.
Raymond S; Nicot F; Carcenac R; Lefebvre C; Jeanne N; Saune K; Delobel P; Izopet J
J Antimicrob Chemother; 2018 May; 73(5):1152-1157. PubMed ID: 29444253
[TBL] [Abstract][Full Text] [Related]
14. High Prevalence of HIV Low Abundance Drug-Resistant Variants in a Treatment-Naive Population in North Rift Kenya.
Cheriro W; Kiptoo M; Kikuvi G; Mining S; Emonyi W; Songok E
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1274-7. PubMed ID: 26414430
[TBL] [Abstract][Full Text] [Related]
15. Application of Single-Tube Tri-Primer ARMS-PCR to Detect the NFKB1 ATTG Insertion/Deletion Polymorphism.
Chao J; Chai L; Yin X; Zhou Z; Xu S; Zhu W; Deng Y
Genet Test Mol Biomarkers; 2018 Jul; 22(7):443-447. PubMed ID: 30020835
[TBL] [Abstract][Full Text] [Related]
16. Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.
Kapoor A; Jones M; Shafer RW; Rhee SY; Kazanjian P; Delwart EL
J Virol; 2004 Jul; 78(13):7112-23. PubMed ID: 15194787
[TBL] [Abstract][Full Text] [Related]
17. Low abundance drug resistance variants in transmitted HIV drug resistance surveillance specimens identified using tagged pooled pyrosequencing.
Ji H; Liang B; Li Y; Van Domselaar G; Graham M; Tyler S; Merks H; Sandstrom P; Brooks J
J Virol Methods; 2013 Feb; 187(2):314-20. PubMed ID: 23159670
[TBL] [Abstract][Full Text] [Related]
18. An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.
Simen BB; Braverman MS; Abbate I; Aerssens J; Bidet Y; Bouchez O; Gabriel C; Izopet J; Kessler HH; Stelzl E; Di Giallonardo F; Schlapbach R; Radonic A; Paredes R; Recordon-Pinson P; Sakwa J; St John EP; Schmitz-Agheguian GG; Metzner KJ; Däumer MP;
J Virol Methods; 2014 Aug; 204():31-7. PubMed ID: 24731928
[TBL] [Abstract][Full Text] [Related]
19. Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients.
Epaulard O; Signori-Schmuck A; Larrat S; Kulkarni O; Blum MG; Fusillier K; Blanc M; Leclercq P; François O; Morand P
J Clin Virol; 2017 Oct; 95():13-19. PubMed ID: 28830014
[TBL] [Abstract][Full Text] [Related]
20. HIV Drug Resistance Testing in a Resource Limited Setting with High Viral Diversity: The First Twenty Eight Months Experience.
Ngo-Malabo ET; Ngoupo PA; Sadeuh-Mba SA; Akongnwi E; Banaï R; Ngono L; Bilong-Bilong CF; Kfutwah A; Njouom R
Curr HIV Res; 2017; 15(4):297-305. PubMed ID: 28745207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
